SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Library > On-Demand Supplier Webinar

Targeted Product Development: Personalized Medicine versus Orphan Product Development

Published: 31-Jul-2012 | Format: Webinar | Document type: Supplier Webinar
Related applications: Regulatory affairs , Validation services
Rho

The development of therapeutics for personalized medicine leverages many of the advantages of the legislation conferred upon orphan products. New products must be positioned intelligently to take advantage of this legislation. Join David Shoemaker, Ph.D. as he discusses the benefits of orphan product designation in the US, EU, and strategies for obtaining these designations for novel products.

Speaker:

  • David Shoemaker

    David Shoemaker

    Senior Vice President R&D

    Rho